Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 17.30
-0.20 (-1.14%)
At close: Nov 28, 2025
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 99.78 million as of November 28, 2025. Its market cap has decreased by -39.24% in one year.
Market Cap
99.78M
Enterprise Value
247.29M
Revenue
839.38K
Ranking
n/a
PE Ratio
3.81
Stock Price
17.30
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 99.78M, a decrease of -58.50%. That is a compound annual growth rate of -20.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 99.78M | -31.58% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 264.79B |
| Novartis AG | 200.78B |
| Lonza Group AG | 38.40B |
| Galderma Group AG | 37.87B |
| Alcon | 31.41B |
| Sandoz Group AG | 24.20B |
| Straumann Holding AG | 14.91B |
| Sonova Holding AG | 11.99B |